pharmaphorum7d
FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease
The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...
Verywell Health on MSN10mon
Jardiance vs. Farxiga: Similarities and Differences
Jardiance comes in the following tablet strengths: 10 milligrams (mg) and 25 mg Farxiga comes in the ... while Farxiga is ...
Benzinga.com1mon
STAT+: With a major patent cliff coming, will JPM play host to some serious deal-making?
Drug companies stand to lose more than $400 billion in revenue as patents expire for Keytruda, Eliquis, Jardiance, Opdivo, and other blockbuster therapies. (By comparison, the last major patent ...
pharmaphorum2y
FDA approves Jardiance (empagliflozin) for wider range of patients with heart failure
Jardiance is also authorised to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. According to the FDA, heart disease impacts more than ...